REDWOOD CITY, CA--(Marketwire - June 27, 2012) - BioCentury Publications Inc., the internationally respected source of biopharma business intelligence, received the Commentator of the Year award at the European Mediscience Awards. The award, sponsored by College Hill Life Sciences, recognizes the importance of clear and concise commentary on the mediscience sector. It is awarded to the person or team that provides sharp, perceptive and penetrating commentary about the sector and excellence in the way that knowledge is communicated to the wider audience.
“We are honored to have won this prestigious award,” said David Flores, President & CEO of BioCentury. “We appreciate the international recognition of the dedication and effort that the BioCentury team makes on a daily basis to provide value-added information, data and analysis to the global biopharma industry.”
In its 11th year, the European Mediscience Awards celebrate the best in the healthcare, medical, pharmaceutical, biotechnology and life sciences sectors. The award ceremony is sponsored by Nomura Code and organized by Ford Sinclair. This year’s ceremony was held in London, England.
About BioCentury
Now in its 20th year, BioCentury Publications, Inc. provides essential biopharma industry intelligence to a global audience of biotech and pharmaceutical executives, investors, public policy specialists and the scientific community. This audience has benefited from BioCentury’s deep knowledge, data-driven analysis, independent perspective and trustworthy content available through the company’s publications, data products and collaborative industry conferences in the U.S., Europe and Asia.
BioCentury’s titles include the flagship BioCentury®, the Bernstein Report on BioBusiness; its SciBX: Science-Business eXchange™ translational science partnership with Nature Publishing Group; and its BioCentury Extra™ online daily newspaper. These timely journals are backed by BCIQ: BioCentury Online Intelligence™, an online business intelligence resource. BioCentury also produces its BioCentury This Week biotech public affairs television program in partnership with the Gannett-owned WUSA9 CBS affiliate in Washington, D.C. The program is aired in Washington each Sunday as part of the WUSA9 “Sunday Morning Power Block,” and distributed globally online at www.biocenturytv.com.
For more information, visit www.biocentury.com and www.biocenturytv.com.
